- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Seelos Therapeutics Inc.
Headquarters: New York, NY, United States
Website: https://www.seelostherapeut...
Year Founded: 2016
Status: Public
Industry Sector: HealthTechnology
CEO: Raj Mehra, PhD, MBA
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: 0
Exchange/Ticker 1: NASDAQ:SEEL
Exchange/Ticker 2: N/A
Latest Market Cap: N/A
BioCentury | May 10, 2024
Product Development
Epigenetic editors at ASGCT: animal models address the durability question
As the new modality advances, the promise of durability is bearing out in preclinical models
BioCentury | Dec 3, 2021
Data Byte
The α-synuclein pipeline as Novartis, UCB enter deal
Novartis pays $150M to share rights to small molecule and gain option to a mAb
BioCentury | Jul 10, 2021
Translation in Brief
Host genes associated with COVID susceptibility; plus Sana, Pfizer, Verge, Seelos and Pathios
BioCentury’s roundup of translational news
BioCentury | Jun 5, 2021
Targets & Mechanisms
Going beyond genetic medicines for muscular dystrophy
Muscular dystrophy programs in the clinic cover not only a range of muscle mechanisms but also anti-fibrotic and anti-inflammation ones
BioCentury | Jan 30, 2021
Product Development
ALS looks up as clinical pipeline explodes
Three late-stage readouts this year and multiple mechanisms in the clinic could lift the lid on ALS treatments
Items per page:
1 - 7 of 7